0078-1028 : Vijoice 125 mg Oral Tablet
| NDC: | 0078-1028 |
| Labeler: | Novartis Pharmaceuticals Corporation |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Vijoice |
| Dosage Form: | Oral Tablet |
| Application #: | NDA215039 |
| Rev. Date: |
NDC Package Codes:
- 0078-1028-84: 1 BLISTER PACK IN 1 CARTON (0078‑1028‑84) > 28 TABLET IN 1 BLISTER PACK (0078‑1028‑51)
- 0078-1028-91: 1 BLISTER PACK IN 1 CARTON (0078‑1028‑91) > 28 TABLET IN 1 BLISTER PACK (0078‑1028‑90)
Active Ingredients:
- Alpelisib
Dosage Strength:
- 125 mg
Related Products:
Based on records with the same trade name.- 0078-1021 Vijoice 50 mg Oral Tablet by Novartis Pharmaceuticals Corporation
- 0078-1035 VijoiceVijoice Kit by Novartis Pharmaceuticals Corporation
- 0078-1175 Vijoice 50 mg Oral Granule by Novartis Pharmaceuticals Corporation
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 0078-1021Next: 0078-1035 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.